Prof. Seung Hyun Lee, MD, PhD - GS TS BS. Phạm Mạnh Hùng - PGS TS BS. Nguyễn Thị Thu Hoài - PGS TS BS. Lê Minh Khôi - Assoc. Prof. Jaehyuk Choi, MD, PhD - TS BS. Trần Hòa - TS BS. Phan Tuấn Đạt - TS BS. Nguyễn Quốc Thái
MitraClip case presentation
Mechanisms of mitral regurgitation and anatomical criteria
Real‑time imaging and device positioning
Management of complications and outcome optimization
Case in a box: Transcatheter edge-to-edge mitral valve repair
Discussion and summary
Defining severe aortic stenosis: When is it truly severe?
Role of echocardiography, CT calcium scoring, and stress testing
When to perform TAVI, when SAVR, and when to observe?
Sutureless aortic valve replacement: Evidence-based indications and technical considerations
Discussion
Introduction
Clinical Case: Severe aortic stenosis
How would I treat
How did I treat
Discussion and summary
TS BS CKII. Nguyễn Tri Thức - PGS TS BS. Nguyễn Hoàng Bắc - GS TS BS. Lê Ngọc Thành - GS TS BS. Huỳnh Văn Minh - GS TS BS. Nguyễn Lân Việt - GS TS BS. Đặng Vạn Phước - GS TS BS. Bùi Đức Phú - PGS TS BS. Phạm Nguyễn Vinh - GS TS BS. Trương Quang Bình - GS TS BS. Phạm Mạnh Hùng - PGS TS BS. Châu Ngọc Hoa - PGS TS BS. Nguyễn Lân Hiếu - PGS TS BS. Trương Đình Cẩm - PGS TS BS. Lê Văn Trường - Prof. Geu-Ru Hong, MD, PhD - PGS TS BS. Nguyễn Hoàng Định - PGS TS BS. Nguyễn Thị Thu Hoài - PGS TS BS. Lê Minh Khôi - PGS TS BS. Nguyễn Ngọc Quang - PGS TS BS. Đỗ Kim Quế - PGS TS BS. Phạm Trường Sơn - PGS TS BS. Hoàng Văn Sỹ - PGS TS BS. Hoàng Anh Tiến - Assistant Prof. Kyu-Yong Ko, MD - TS BS. Vũ Hoàng Vũ - ThS BS. Phan Kim Phương
Remarks by the Director of University Medical Center Ho Chi Minh City
Remarks by the Deputy Minister of Health
Remarks by the President of ACTSVN
Remarks by the President of VNHA
Sponsor Appreciation
Global Update on TAVI, TEER, TPVI
Structural heart interventions in Vietnam: Where do we stand?
TAVI: The next step for low‑risk and asymptomatic patients
Acute heart valve emergency
Vietnam’s vision for transcatheter valve therapy
Discussion
Preference Pathways for TAVI vs SAVR in South Korea
Why develop a Vietnamese consensus for aortic valve replacement?
Vietnam’s consensus on transcatheter aortic valve replacement
Establishing a Vietnamese THV outcomes registry
Discussion
Young, low‑risk patients: I choose SAVR
Young, low‑risk patients: I choose TAVI
Q&A
Case 1
Discussion
Case 2
Discussion
Case 3
Discussion
Case 4
Discussion
Hydravalve update and case sharing
Discussion
Summary
Primary and secondary MR: Key echocardiographic parameters
Left ventricular function and size in intervention decision‑making
Which patients benefit most from TEER compared to surgery
Role of the heart team in borderline or high‑risk cases
Discussion and summary
Heart failure management in patients with valvular heart disease
ARNI in heart failure and MR
Cardiac surgery associated acute kidney injury: Diagnosis, treatment and prevention
Type 2 diabetes and the risk of valvular heart disease: The role of SGLT2 inhibitors
The role of SGLT2 inhibitors in patients with heart failure and concomitant valvular heart disease
Discussion
Optimizing Beta-Blockers in HFrEF
Atrial fibrillation and heart failure management: Challenges and opportunities
Screening and treatment of heart failure in atrial fibrillation patients
Emerging trends in rhythm and rate control in atrial fibrillation patients
Stroke prevention in atrial fibrillation: sooner is better?
Role of interventions in atrial fibrillation management: How and when?
Discussion
3D TEE for TEER and TAVI Planning
Echocardiography case
Photon-Counting CT Technology in the Evaluation of Cardiovascular and Valvular Diseases
Discussion
Understanding 3-Mensio report - key considerations
Live case analysis by a 3-Mensio expert
Discussion
Practice on procedural simulation for Tavi (Navitor and Flexnav) and Mitral Clip (G4)
How to optimize clinical outcomes with the latest generation intra-annular SE TAVI devices
How to optimize TAVI outcomes in patients with small annular
Practice on procedural simulation for Tavi (Navitor and Flexnav) and Mitral Clip (G4)
TEER Imaging guidance from Diagnostic and Procedure (Step by Step)
Practice on procedural simulation for Tavi (Navitor and Flexnav) and Mitral Clip (G4)
Live case 1 presentation
Bicuspid Aortic Valve Disease: Why BEV maybe the preferred TAVR platform?
Best clinical practice: Tips and tricks for bicuspid aortic valve cases
LIVE CASE 1: TAVI in bicuspid aortic valve patient
FX >> Pro: How many and how? Let push barrier by FX: It's not TAVI, It's EvolutTM
Latest evidence for TAVI in female patients with small aortic annuli (RHEA and SMART trials)
Introduction to live case 2
LIVE CASE 2
First THV options for future valve replacement
Ensuring long‑term valve durability
TAVI in asymptomatic severe AS: Should any or specific TAVI device be recommended?
PCI first or TAVI first in patients with concomitant CAD and severe AS?
Discussion
1‑year results of landmark trials
Presentation of live sase 3
LIVE CASE 3 (Myval)
Discussion
Closing
Interventional Imaging: Present and future
Planning access and commissural alignment
Valve‑in‑valve prediction tool
CT for aortic annulus and root
Post-TAVI: Single antiplatelet, dual antiplatelet, or anticoagulation?
Management of valve thrombosis and bleeding risk
TAVI valve‑in‑valve: Antiplatelet or anticoagulant therapy?
Rhythm vs. rate control in TEER/TAVI patients
Stroke prevention: DOACs, left atrial appendage occlusion (LAAO), etc.
Heart team approach for concomitant interventions
Discussion
Case 1
Case 2
Discussion
TAVI‑first vs. SAVR‑first: Determinant factors
Future perspectives on valve‑in‑valve
Role of aortic root enlargement and coronary access
Discussion
Aortic root enlargement at Ho Chi Minh City Heart Institute
THV applications for new indications (asymptomatic patients, moderate AS)
Highlighting new developments in THV
Discussion